Jean Cahn

Title: Jean Cahn: Innovator in Cardiovascular Treatments

Introduction

Jean Cahn is a notable inventor based in Montrouge, France. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that exhibit calcium blocking activity. His work has implications for the treatment of cardiovascular diseases and disturbances in cerebral circulation.

Latest Patents

Cahn holds 2 patents that highlight his innovative approach to drug development. One of his latest patents describes compounds having calcium blocking activity, specifically a compound prepared by reacting bis-(2-(3,4-dimethoxy-phenyl)ethyl)amine with formaldehyde in a reducing medium. This compound is effective in treating cardiovascular diseases and improving cerebral circulation. Another patent focuses on a calcium antagonistic dihydropyridine derivative, which is prepared by reacting m-nitrobenzaldehyde, ethyl .beta.-aminocrotonate, and 2-piperidinoethanol acetoacetate. This compound demonstrates valuable pharmacological properties, including calcium antagonistic activity both in vitro and in vivo.

Career Highlights

Throughout his career, Jean Cahn has worked with various companies, including Yason S.r.l. and Sir International S.a. His expertise in pharmacology and innovative thinking has allowed him to contribute significantly to the field.

Collaborations

Cahn has collaborated with notable individuals in his field, including his coworker Giuseppe Quadro. Their joint efforts have further advanced the research and development of effective pharmaceutical compounds.

Conclusion

Jean Cahn's contributions to the field of pharmacology, particularly through his innovative patents, have the potential to improve treatments for cardiovascular diseases. His work exemplifies the importance of innovation in medical science.